Literature DB >> 21652011

Notch-ing from T-cell to B-cell lymphoid malignancies.

Leonardo Mirandola1, Paola Comi, Everardo Cobos, W Martin Kast, Maurizio Chiriva-Internati, Raffaella Chiaramonte.   

Abstract

Notch receptors are transmembrane proteins critically determining cell fate and maintenance of progenitor cells in many developmental systems. Notch signaling is involved in stem cell self-renewal and regulates the main functions of cell life at different levels of development: cell proliferation, differentiation and apoptosis. By virtue of its involvement in the regulation of cell physiology, it is not surprising that a deregulation of the Notch pathway leads to the development of different tumors. In this review, we critically discuss the latest findings concerning Notch roles in hematologic oncology, with a special focus on T-cell acute lymphoblastic leukemia and B-cell malignancies. We also describe the molecular mediators of Notch-driven oncogenic effects and the current pharmacological approaches targeting Notch signaling.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652011     DOI: 10.1016/j.canlet.2011.05.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.

Authors:  Shumei Song; Dipen M Maru; Jaffer A Ajani; Chia-Hsin Chan; Soichiro Honjo; Hui-Kuan Lin; Arlene Correa; Wayne L Hofstetter; Marta Davila; John Stroehlein; Lopa Mishra
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

Review 2.  The challenge of targeting notch in hematologic malignancies.

Authors:  Fiorela N Hernandez Tejada; Jorge R Galvez Silva; Patrick A Zweidler-McKay
Journal:  Front Pediatr       Date:  2014-06-10       Impact factor: 3.418

3.  Notch signaling drives multiple myeloma induced osteoclastogenesis.

Authors:  Michela Colombo; Katja Thümmler; Leonardo Mirandola; Silvia Garavelli; Katia Todoerti; Luana Apicella; Elisa Lazzari; Marialuigia Lancellotti; Natalia Platonova; Moeed Akbar; Maurizio Chiriva-Internati; Richard Soutar; Antonino Neri; Carl S Goodyear; Raffaella Chiaramonte
Journal:  Oncotarget       Date:  2014-11-15

Review 4.  Molecularly targeted therapies in multiple myeloma.

Authors:  Pilar de la Puente; Barbara Muz; Feda Azab; Micah Luderer; Abdel Kareem Azab
Journal:  Leuk Res Treatment       Date:  2014-04-16

5.  Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.

Authors:  Liang Lin; Fan Yan; Dandan Zhao; Meng Lv; Xiaodong Liang; Hui Dai; Xiaodan Qin; Yan Zhang; Jie Hao; Xiuyuan Sun; Yanhui Yin; Xiaojun Huang; Jun Zhang; Jin Lu; Qing Ge
Journal:  Oncotarget       Date:  2016-03-01

Review 6.  Notch signaling deregulation in multiple myeloma: A rational molecular target.

Authors:  Michela Colombo; Serena Galletti; Silvia Garavelli; Natalia Platonova; Alessandro Paoli; Andrea Basile; Elisa Taiana; Antonino Neri; Raffaella Chiaramonte
Journal:  Oncotarget       Date:  2015-09-29

7.  Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.

Authors:  You Zou; Fang Fang; Yong-Jun Ding; Meng-Yuan Dai; Xing Yi; Chen Chen; Ze-Zhang Tao; Shi-Ming Chen
Journal:  Mol Med Rep       Date:  2016-08-29       Impact factor: 2.952

Review 8.  Genomic characterization of acute leukemias.

Authors:  Sabina Chiaretti; Valentina Gianfelici; Giulia Ceglie; Robin Foà
Journal:  Med Princ Pract       Date:  2014-06-20       Impact factor: 1.927

9.  Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.

Authors:  Michela Colombo; Serena Galletti; Gaetano Bulfamante; Monica Falleni; Delfina Tosi; Katia Todoerti; Elisa Lazzari; Leslie A Crews; Catriona H M Jamieson; Sara Ravaioli; Francesco Baccianti; Silvia Garavelli; Natalia Platonova; Antonino Neri; Raffaella Chiaramonte
Journal:  Oncotarget       Date:  2016-08-30

Review 10.  Notch and its oncogenic activity in human malignancies.

Authors:  Marlena Brzozowa-Zasada; Adam Piecuch; Marek Michalski; Oliwia Segiet; Józef Kurek; Marzena Harabin-Słowińska; Romuald Wojnicz
Journal:  Eur Surg       Date:  2017-09-18       Impact factor: 0.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.